U.S. Life Sciences Stock News

Perimeter Solutions (NYSE:PRM) is dealing with operational and safety issues at its Sauget P2S5 facility that have led to reduced production and ongoing litigation as it seeks to take control of the site. The company has recently closed a sizeable acquisition while shifting more of its portfolio toward fixed and recurring contracts to support more consistent earnings. These developments affect a key production asset and the structure of Perimeter Solutions' revenue, with potential...

In recent weeks, UGI Utilities has begun additional natural gas system upgrades in Lancaster and implemented higher purchased gas cost rates, while its proposal for a US$99.40 million annual distribution rate increase has been temporarily suspended by the Pennsylvania Public Utility Commission for further review. Together, these infrastructure investments, customer bill impacts, and regulatory oversight highlight how UGI’s earnings profile is closely tied to state-level rate decisions and...

IDACORP, Inc. recently reported its full-year 2025 results, with sales of US$1.81 billion, revenue of US$1.81 billion, and net income rising to US$323.47 million, alongside higher basic and diluted earnings per share from continuing operations compared with 2024. At the same time, the company issued 2026 earnings guidance of US$6.25 to US$6.45 per diluted share, highlighting management’s expectations while signaling limited use of additional tax credits under Idaho’s regulatory...

Syndax Pharmaceuticals secured its third FDA approval within a year, following the launches of Revuforj and Niktimvo. The company is rapidly shifting into a commercial-stage model with revenues now coming from multiple newly approved therapies. Pivotal clinical trials are in progress that could support label expansions and additional indications. Syndax Pharmaceuticals, NasdaqGS:SNDX, is moving from a pure R&D story to an active commercial player, supported by three FDA approved therapies...

Flywire appointed Patrick Blanc as Chief Technology Officer as part of a leadership realignment focused on AI driven product development. Blanc brings payments technology experience from senior roles at Ingenico, Visa, and PayPal. David King moved into the role of Chief Product Officer and Co President of Global Education to support Flywire's product and sector focus. For investors tracking NasdaqGS:FLYW, this leadership reshuffle comes with the stock recently closing at $12.31 and showing...

Republic Airways Holdings (RJET) has drawn fresh attention after recent trading, with the stock up 1.7% on the day and double digit gains over the past month and the past 3 months. See our latest analysis for Republic Airways Holdings. With the latest share price at $21.73, a 1 day share price return of 1.7% builds on a 7 day gain of 10.0% and a 30 day share price return of 26.3%. The year to date move of 10.8% suggests momentum has picked up recently compared with earlier in the year. If...

Chewy appointed Christopher S. Deppe as its new Chief Financial Officer after an extensive search. Deppe previously served as Head of Corporate and Commercial Finance at Chewy and held senior leadership roles at Amazon. This is Chewy’s first major permanent executive appointment following an interim period in the finance role. For investors watching NYSE:CHWY, a permanent CFO is a key piece of the puzzle. Chewy’s shares recently closed at $27.42, with a 3.7% gain over the past week but...

If you are wondering whether Qorvo at around US$82.90 still offers value or is pricing in too much optimism already, you are not alone. The stock has returned 0.8% over the last 7 days and 6.1% over the last 30 days, while the year to date return sits at a 3.9% decline and the 1 year return is 14.0%. This compares to a 19.3% decline over 3 years and a 51.6% decline over 5 years. Recent coverage of Qorvo has focused on its role within the semiconductor sector and how investor expectations are...

Recent Share Performance Snapshot Prestige Consumer Healthcare (PBH) has seen mixed share performance recently, with a 1 day return of roughly a 1.3% decline, a flat result over the past week, and gains over the month and past 3 months. Over longer periods the picture is split, with a 13.2% gain year to date and a 14.9% total return over 3 years, set against an 18.2% total return decline over the past year. See our latest analysis for Prestige Consumer Healthcare. At a share price of $69.30,...

In February 2026, QCR Holdings, Inc. announced that its Board of Directors approved a cash dividend of US$0.10 per share, payable on April 3, 2026, to shareholders of record as of March 19, 2026, raising the quarterly payout from US$0.06 per share. This sizable step-up in the regular dividend highlights management’s emphasis on returning capital to shareholders while signaling confidence in the company’s financial position. Next, we’ll examine how this materially higher quarterly dividend...

If you are wondering whether Alkami Technology is starting to look interesting at its current share price, this article will walk through what that price actually implies about the company. The stock last closed at US$16.55, with returns of a 2.8% decline over 7 days, a 21.9% decline over 30 days, a 27.1% decline year to date and a 46.4% decline over the past year, while the 3 year return sits at 7.1%. These moves come as investors continue to track company specific developments and the...

Capri Holdings has appointed Tyler Reddien as Chief Financial Officer and Chief Operating Officer, effective March 30, 2026, with interim CFO Rajal Mehta returning to his prior role as Michael Kors brand CFO. The consolidation of finance and operations leadership under Reddien, who brings experience from The Body Shop, Natura &Co, Hertz, and United Airlines, could influence how Capri pursues performance improvement and transformation across its global portfolio. Next, we’ll examine how...

If you are wondering whether DigitalOcean Holdings is still attractively priced after its recent run, you are not alone. This article will help you weigh what the current share price really reflects. The stock most recently closed at US$56.06, with returns of 1.5% over the last 30 days, 14.5% year to date, and 30.8% over the past year. The last 7 days showed an 11.9% decline that may have changed how some investors see the risk and reward trade off. Recent news coverage has focused on...

Buenaventura (NYSE:BVN) has approved a higher dividend payout policy, supported by strong operating cash flow. The Board also cleared a higher dividend distribution to shareholders under the new framework. The San Gabriel project is approaching completion, with ramp up reported as close to finished. For you as an investor, the combination of a higher dividend payout policy and a near complete San Gabriel ramp up is a key development for Compañía de Minas Buenaventura, a precious metals...

If you are wondering whether OGE Energy is still fairly priced after its recent run, or if the current share price is giving you a margin of safety, this article walks through what the numbers say about value. With the stock at US$49.14 and returns of 3.8% over 7 days, 12.5% over 30 days, 14.6% year to date, 10.3% over 1 year, 56.3% over 3 years and 93.0% over 5 years, many investors are asking whether the current price still makes sense. Recent attention on OGE Energy has focused on how a...

If you are wondering whether LegalZoom.com’s current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value. The stock last closed at US$7.03, with a 7 day return of 7.2%, but declines of 20.9% over 30 days, 26.7% year to date, and 30.8% over the past year. These moves have put valuation questions front and center for many investors, who are weighing short term swings against the longer term picture. Evergreen coverage like this aims...

Amneal Pharmaceuticals (NasdaqGS:AMRX) reported strong Q4 2025 results, highlighting progress across specialty, injectables, biosimilars, and complex generics. The company announced multiple product launches and regulatory approvals, expanding its presence in higher value segments. Management highlighted a promising pipeline, including biosimilars expected to enter the US market. Amneal also emphasized its collaboration with Pfizer on GLP-1 therapies as a key focus area for future...

Caris Life Sciences (NasdaqGS:CAI) reported an interim readout from its Achieve 1 study for the Caris Detect multi cancer early detection blood test. The interim data show sensitivity and specificity that the company says outperform current methylation based approaches. Caris is adding Whole Transcriptome Sequencing to Caris Detect to deepen molecular resolution in the test. The company also introduced a new AI powered breast cancer signature in its Molecular Tumor Board Report to expand...

Oncolytics Biotech (NasdaqCM:ONCY) has completed patient enrollment in its Phase 1/2 GOBLET study. The company is moving ahead with pivotal trials in squamous cell anal cancer and metastatic colorectal cancer. Management is shifting clinical focus and resources toward these rare cancer indications and planning FDA interactions related to potential approval pathways. Oncolytics Biotech focuses on cancer therapies, and the GOBLET study sits at the center of that effort. With enrollment now...

Daktronics (NasdaqGS:DAKT) has agreed to supply an integrated digital display system across the OCVIBE campus, a large mixed-use development project. The company also announced an executive leadership change, with the former Interim President and CEO moving into an advisory role. Both updates relate to Daktronics' positioning in large commercial installations and its ongoing leadership structure. Daktronics focuses on electronic scoreboards, digital signage, and large-format LED video...

Reliance, Inc. (NYSE:RS) raised its quarterly dividend. The company is continuing its long term share buyback program. Both actions reflect management’s current approach to capital allocation and shareholder distributions. Reliance, Inc. (NYSE:RS) operates in the metals service center space, supplying processed metal products to a wide range of end markets. In that kind of business, decisions around dividends and buybacks can matter as much to investors as day to day price moves for steel...

VEON and ride hailing operator Hala have signed a Memorandum of Understanding to expand mobility services in frontier markets. The partnership aims to combine Hala's ride hailing capabilities with VEON's digital platforms and local presence. The agreement builds on VEON's existing mobility offerings and Hala's scale in Dubai to broaden VEON's digital ecosystem beyond telecom. NasdaqGS:VEON currently trades at $55.89, with a return of 24.9% over the past year and a very large gain over three...

Richtech Robotics: Context for Recent Stock Performance Richtech Robotics (RR) has drawn attention after a recent stretch of weak trading, with the stock showing negative returns over the past week, month, and past 3 months. That price action has investors rechecking the story behind this US robotics player. See our latest analysis for Richtech Robotics. At a share price of $2.49, Richtech Robotics has seen momentum fade recently, with a 1 month share price return of 30.45% and a year to date...

Ginkgo Bioworks Holdings (DNA) is back in focus after reporting 2025 results that combined smaller losses and lower cash burn with a clear pivot toward robotics-powered autonomous labs and a planned biosecurity divestiture. See our latest analysis for Ginkgo Bioworks Holdings. The earnings release, biosecurity divestiture plan, and new autonomous lab contracts have coincided with heavy selling, including a 30.48% 1-day share price return decline and a 26.79% 7-day share price return decline...